Advertisement

Expert Point of View: Julie A. Margenthaler, MD


Advertisement
Get Permission

Julie A. Margenthaler, MD

Julie A. Margenthaler, MD

“Lymphedema represents a significant morbidity for patients who experience it,” commented Julie A. Margenthaler, MD, of Washington University School of Medicine, St. Louis. “This study [PREVENT] demonstrates that bioimpedance spectroscopy can identify early signs of lymphedema, so interventions can be taken to prevent its progression. This is an important step in improving the lives of our breast cancer survivors.” 

DISCLOSURE: Dr. Margenthaler reported no conflicts of interest.


Related Articles

Using Bioimpedance Spectroscopy to Prevent Progression of Lymphedema

Surveillance of women at risk for breast cancer–related lymphedema using bioimpedance spectroscopy was more effective in preventing lymphedema progression than traditional measurement of arm circumference, when each is combined with immediate compression therapy. These findings came from the...

Advertisement

Advertisement



Advertisement